APA aipamena

Cressman, S., Karsan, A., Hogge, D., McPherson, E., Bolbocean, C., Regier, D., & Peacock, S. (2016). Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia. Wiley.

Chicago Style aipamena

Cressman, S., A. Karsan, DE Hogge, E. McPherson, C. Bolbocean, DA Regier, and SJ Peacock. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.

MLA aipamena

Cressman, S., et al. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.